VeriMomIst aesculus hippocastanum fruit powder in der Schwangerschaft sicher?
No EU Annex II (ban) or Annex III (restriction) listing or harmonised CLP reproductive classification was identified for Aesculus hippocastanum (CAS 8053‑39‑2). Authoritative reviews (EMA assessment, NCCIH) state safety in pregnancy/lactation is not established and recommend avoidance for lack of data rather than reporting proven reproductive toxicity; peer‑reviewed reviews of topical cosmetic uses report limited adverse effects (contact dermatitis) but not developmental/reproductive hazards. Thus there is no direct evidence of reproductive hazard, but exposure from topical use is considered low but measurable. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
Related ingredients
Frequently asked questions
- Ist aesculus hippocastanum fruit powder in der Schwangerschaft sicher?
- No EU Annex II (ban) or Annex III (restriction) listing or harmonised CLP reproductive classification was identified for Aesculus hippocastanum (CAS 8053‑39‑2). Authoritative reviews (EMA assessment, NCCIH) state safety in pregnancy/lactation is not established and recommend avoidance for lack of data rather than reporting proven reproductive toxicity; peer‑reviewed reviews of topical cosmetic uses report limited adverse effects (contact dermatitis) but not developmental/reproductive hazards. Thus there is no direct evidence of reproductive hazard, but exposure from topical use is considered low but measurable. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
- Ist aesculus hippocastanum fruit powder während des Stillens sicher?
- Same rationale as pregnancy: no harmonised reproductive/CMR classification or EU ban/restriction found; EMA/NCCIH note insufficient data and advise caution. Maternal topical exposure could lead to low but measurable systemic exposure; no infant‑specific toxicity data were found. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
- Ist aesculus hippocastanum fruit powder sicher für Babyhaut?
- No evidence of intrinsic reproductive or developmental toxicity to infants from topical exposure to cosmetic‑grade horse‑chestnut extract. Because baby skin (0–3 yr) has higher permeability and surface‑area‑to‑weight, exposure score is increased by +1 relative to adults (topical adult e=1 → baby e=2). Reports flag contact dermatitis cases but not systemic developmental effects. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18503457/?utm_source=openai))
- Wie bewertet VeriMom aesculus hippocastanum fruit powder?
- VeriMom bewertet aesculus hippocastanum fruit powder mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu aesculus hippocastanum fruit powder?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu aesculus hippocastanum fruit powder basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.